- NSE
Krebs Biochem.&Inds
Healthcare NSE:KREBSBIO
57.15INR
9.52
(
19.99%)
Last update at April 6, 2026, midnight
Day Range
52 Week Range
Fundamentals
- Previous Close 47.63
- Market Cap 1453.42M
- Volume29,930
- P/E Ratio -
- EBITDA -148.60M
- Revenue TTM 272.16M
- Revenue Per Share TTM 12.63
- Gross Profit TTM 205.73M
- Diluted EPS TTM -12.74
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Past Performance
| Status | Stocks | Entry Price | Entry Date | Exit Date | Duration | Duration Type | Sector | *Return(%) |
|---|---|---|---|---|---|---|---|---|
| CLOSED | CIPLA | ₹ 1515.70 | 4/11/25 | 4/11/25 | Same Day | Short Term | Healthcare | -0.79% |
| CLOSED | CIPLA | ₹ 1499.85 | 18/03/25 | 18/03/25 | Same Day | Short Term | Healthcare | 0.72% |
| CLOSED | CIPLA | ₹ 1452.00 | 11/03/25 | 11/03/25 | Same Day | Short Term | Healthcare | 0.69% |
| CLOSED | CIPLA | ₹ 1457.00 | 14/02/25 | 14/02/25 | Same Day | Short Term | Healthcare | 0.24% |
Financials
Income Statement
Balance Sheet
Change in Cash
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Income before tax | -269.24M | -197.28M | -246.92M | -445.27M | -283.59M |
| Net income | -269.39M | -197.28M | -246.92M | -445.27M | -283.59M |
| Total Revenue | 433.12M | 504.22M | 521.34M | 597.03M | 386.06M |
| Gross Profit | 377.56M | -108.75M | 244.19M | -57.64M | -136.26M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 1690.36M | 1781.75M | 1749.82M | 1898.06M | 1592.20M |
| Intangible assets | 23.19M | 25.03M | 26.87M | 28.71M | 35.10M |
| Other current assets | 38.40M | 23.33M | 32.18M | 79.48M | 34.40M |
| Deferred long term liab | - | - | - | 10.24M | 16.62M |
| Non current assets other | - | - | - | - | - |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Change in Cash | 0.04M | 0.52M | -0.15M | -6.10M | 5.36M |
| Operating Cash | -78.91M | 23.04M | -247.13M | -172.16M | -145.75M |
| Free Cash Flow | -114.54M | -70.50M | -355.84M | -407.36M | -400.81M |
Peer Comparison
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
| Company | Change | Price | Market Cap (M) | P/E Ratio |
|---|---|---|---|---|
| KREBSBIO Krebs Biochem.&Inds |
9.52 19.99% | 57.15 | 1453.42 | - |
| SUNPHARMA Sun Pharmaceutical Industries Limited |
1.00 0.06% | 1694.60 | 4224508.76 | 40.32 |
| DIVISLAB Divi's Laboratories Limited |
-35.50 -0.61% | 5821.00 | 1752225.28 | 70.47 |
| TORNTPHARM Torrent Pharmaceuticals Limited |
24.40 0.61% | 4011.60 | 1362716.66 | 63.48 |
| CIPLA Cipla Limited |
8.50 0.71% | 1200.90 | 1183505.97 | 21.74 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.